GW501516 facilitated tumor immune escape by inhibiting phagocytosis

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• The CD47/SIRPα pathway is a key regulator of tumor immune evasion.
• GW501516 (a PPARδ agonist) affects cancer cell metabolism and inflammation, but its role in colon tumor immune escape is unknown.

Purpose of the Study:

• To investigate the mechanism by which GW501516 influences colon tumor immune escape.
• To determine the role of PPARδ in GW501516-mediated effects on CD47 expression and immune evasion.

Main Methods:

• Quantitative PCR (qPCR) to assess CD47 gene expression.
• Western blot analysis for membrane-associated CD47 protein.
• Luciferase reporter assays for gene transcription activity.
• Macrophage co-culture experiments to evaluate phagocytosis.
• PPARδ knockout models and in vivo tumor implantation studies.

Main Results:

• GW501516 treatment upregulated CD47 gene and protein expression in colon cancer cells.
• GW501516 enhanced CD47 gene transcription activity.
• GW501516 suppressed macrophage phagocytic capacity.
• PPARδ knockout abolished GW501516-induced CD47 upregulation.
• GW501516 facilitated tumor immune escape in vivo, an effect reversed by PPARδ loss.

Conclusions:

• GW501516 activates PPARδ to upregulate CD47 expression in colon cancer cells.
• This PPARδ-mediated CD47 upregulation promotes colon tumor immune escape by inhibiting macrophage phagocytosis.